TrialPharmacology research & perspectives2025

A Single Dose, Randomized, Open-Label, Cross-Over Bioequivalence Study of Budesonide Pressurized Metered-Dose Inhaler in Healthy Chinese Subjects.

Kai Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.